Cyclotrons and Positron Emitting Radiopharmaceuticals
AP Wolf, JS Fowler - Physics and Engineering of Medical Imaging, 1987 - Springer
Abstract Positron Emission Tomography is at the present time in a growth phase with an
increasing number of clinical facilities showing interest in the use of PET in routine practice …
increasing number of clinical facilities showing interest in the use of PET in routine practice …
Cyclotrons and positron emitting radiopharmaceuticals
AP Wolf, JS Fowler - 1984 - inis.iaea.org
Positron Emission Tomography is at the present time in a growth phase with an increasing
number of clinical facilities showing interest in the use of PET in routine practice. The …
number of clinical facilities showing interest in the use of PET in routine practice. The …
[PDF][PDF] Innovation through cyclotron/and generator-based Positron Emission Tomography (PET): radiopharmaceuticals: challenges and barriers in receiving market …
G Konwalinka - 2019 - core.ac.uk
A very special thanks to my doctoral supervisor Professor. Dr. med. Peter Bartenstein with
whom I was able to work on an innovative and interesting topic. I thank him for his …
whom I was able to work on an innovative and interesting topic. I thank him for his …
Cyclotrons and positron emission tomography radiopharmaceuticals for clinical imaging
GB Saha, WJ MacIntyre, RT Go - Seminars in nuclear medicine, 1992 - Elsevier
Positron emission tomography (PET) requires positronemitting radionuclides that emit 511-
keV photons detectable by PET imagers. Positron-emitting radionuclides are commonly …
keV photons detectable by PET imagers. Positron-emitting radionuclides are commonly …
[PDF][PDF] PET in drug discovery and development: an introduction
H Scheinin, J Knuuti, M Scheinin - Annals of Medicine, 1999 - Taylor & Francis
The development of a new drug is an extremely expensive and risky venture. The average
cost per a successful new chemical entity is estimated to exceed USD 200 million, and after …
cost per a successful new chemical entity is estimated to exceed USD 200 million, and after …
Radiopharmaceuticals in positron emission tomography: present situation and future perspectives
CO Arroyo - Radiologia, 2016 - pubmed.ncbi.nlm.nih.gov
Positron emission tomography (PET) is an imaging technique that has grown greatly in
recent years. PET is considered a fundamental tool in oncology, and it also has indications …
recent years. PET is considered a fundamental tool in oncology, and it also has indications …
Positron-emitting isotopes produced on biomedical cyclotrons
P McQuade, DJ Rowland, JS Lewis… - Current medicinal …, 2005 - ingentaconnect.com
This review will discuss the production and applications of positron-emitting radionuclides
for use in Positron Emission Tomography (PET), with emphasis on radionuclides that can be …
for use in Positron Emission Tomography (PET), with emphasis on radionuclides that can be …
Special characteristics and potential for radiopharmaceuticals for positron emission tomography
AP Wolf - Seminars in Nuclear Medicine, 1981 - Elsevier
The development of accelerator-produced radionuclides is undergoing a rapid if not
exponential increase worldwide. The single photon emitters gallium-67, thallium-201 (iodine …
exponential increase worldwide. The single photon emitters gallium-67, thallium-201 (iodine …
Positron-Emitting Radiopharmaceuticals
PA Salvadori, E Filidei, A Giorgetti - Nuclear Medicine Textbook …, 2019 - Springer
Positron-Emitting Radiopharmaceuticals | SpringerLink Skip to main content Advertisement
SpringerLink Account Menu Find a journal Publish with us Track your research Search Cart …
SpringerLink Account Menu Find a journal Publish with us Track your research Search Cart …
Radiofármacos PET
IP Sánchez - Revista Española de Medicina Nuclear, 2001 - Elsevier
La tomografía de emisión de positrones es una técnica no invasiva de diagnóstico por
imagen en la que se utilizan radiotrazadores marcados que son administrados al sujeto de …
imagen en la que se utilizan radiotrazadores marcados que son administrados al sujeto de …